Cocrystal Pharma, Inc. (COCP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 225K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 91K | -1.39M | 0 | 21K | 1.36M | 28K | 3.24M | 4.31M | 2.95M | 4.27M | 4.19M | 2.8M |
| COGS % of Revenue | 40.44% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 134K | 1.39M | 0 | -21K | -1.36M | -28K | -3.24M | -4.31M | -2.95M | -4.27M | -4.19M | -2.8M |
| Gross Margin % | 59.56% | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | 109.85% | 5078.57% | 100% | 99.51% | 53.9% | 99.34% | 22.7% | -53.8% | 24.49% | -29.81% | -8.32% | -18.64% |
| Operating Expenses | 2.49M | 3.88M | 2.09M | 2.09M | 981K | 3.2M | 1.8M | 1.14M | 1.21M | 399K | 249K | 1.54M |
| OpEx % of Revenue | 1106.67% | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.21M | 862K | 1.14M | 986K | 981K | 1.17M | 1.8M | 1.14M | 1.21M | 1.4M | 1.85M | 1.54M |
| SG&A % of Revenue | 537.78% | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.37M | 1.62M | 954K | 1.12M | 1.36M | 2.04M | 3.24M | 4.31M | 2.95M | 4.27M | 4.19M | 2.8M |
| R&D % of Revenue | 609.33% | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -91K | 1000K | 0 | -21K | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K |
| Operating Income | -2.36M | -2.48M | -2.09M | -2.11M | -2.34M | -3.23M | -5.04M | -5.45M | -4.16M | -4.67M | -4.44M | -4.34M |
| Operating Margin % | -1047.11% | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -0.64% | 23.19% | 58.57% | 61.31% | 43.7% | 30.78% | -13.48% | -25.56% | 18.65% | -3.64% | 21.97% | 82.24% |
| EBITDA | -2.27M | -2.39M | -1.85M | -2.09M | -2.32M | -3.2M | -5.01M | -5.42M | -4.12M | -4.63M | -4.39M | -4.29M |
| EBITDA Margin % | -1006.67% | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 2.2% | 25.36% | 63.09% | 61.46% | 43.83% | 30.78% | -14.17% | -26.16% | 18.55% | -3.86% | 22.26% | 82.4% |
| D&A (Non-Cash Add-back) | 91K | 91K | 239K | 21K | 25K | 28K | 30K | 33K | 35K | 40K | 53K | 47K |
| EBIT | -2.36M | -2.48M | -2.09M | -2.11M | -2.34M | -3.27M | -5.04M | -5.45M | -4.16M | -5.67M | -6.04M | -4.34M |
| Net Interest Income | 22K | -87K | 22K | 28K | 37K | 55K | 111K | 151K | 220K | 180K | 320K | 140K |
| Interest Income | 22K | -87K | 22K | 28K | 37K | 55K | 111K | 151K | 220K | 180K | 320K | 140K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 |
| Other Income/Expense | 57K | 55K | 40K | 53K | 40K | -36K | 103K | 105K | 202K | 202K | 278K | 173K |
| Pretax Income | -2.3M | -2.43M | -2.05M | -2.06M | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M |
| Pretax Margin % | -1021.78% | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -2.3M | -2.43M | -2.05M | -2.06M | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M |
| Net Margin % | -1021.78% | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 0.09% | 25.72% | 58.51% | 61.54% | 41.84% | 26.84% | -18.58% | -28.25% | 23.76% | 0.82% | 26.93% | 82.95% |
| Net Income (Continuing) | -2.3M | -2.43M | -2.05M | -2.06M | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.17 | -0.18 | -0.19 | -0.20 | -0.23 | -0.32 | -0.49 | -0.53 | -0.39 | -0.44 | -0.41 | -0.41 |
| EPS Growth % | 26.09% | 43.75% | 61.22% | 62.26% | 41.03% | 27.27% | -19.51% | -29.27% | 40% | 20% | 41.43% | 92.61% |
| EPS (Basic) | -0.17 | -0.18 | -0.19 | -0.20 | -0.23 | -0.32 | -0.49 | -0.53 | -0.39 | -0.44 | -0.41 | -0.41 |
| Diluted Shares Outstanding | 13.79M | 11.29M | 10.99M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.15M | 10.06M |
| Basic Shares Outstanding | 13.79M | 11.29M | 10.99M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.17M | 10.15M | 10.06M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |